Literature DB >> 15164953

A comparison study of quality of life in women with fibromyalgia and myofascial pain syndrome.

Emine Handan Tüzün1, Gülnur Albayrak, Levent Eker, Seyhan Sözay, Arzu Daşkapan.   

Abstract

PURPOSE: To compare the quality of life scores of fibromyalgia patients with myofascial pain syndrome patients.
METHOD: Thirty-three fibromyalgia patients, 33 myofascial pain syndrome patients, and 33 age-matched controls completed Beck Depression Inventory and Short Form-36 questionnaires.
RESULTS: Compared with myofascial pain syndrome patients, fibromyalgia patients reported significantly more often fatigue, numbness, tingling, gastrointestinal discomfort, and poor sleep. The mean scores on VAS and on Beck Depression Inventory were significantly higher in fibromyalgia patients than myofascial pain syndrome patients. Patients with fibromyalgia had significantly poorer health than the patients with myofascial pain syndrome in pain, general health, vitality, and role emotional subscales.
CONCLUSIONS: The quality of life profile of fibromyalgia patients is quite different from those in the myosfascial pain syndrome group. Myofascial pain syndrome impacted mostly on physical health whereas fibromyalgia impacted on both physical and mental health.

Entities:  

Mesh:

Year:  2004        PMID: 15164953     DOI: 10.1080/09638280310001639696

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  16 in total

1.  A comparison of quality of life, demographic and clinical characteristics of Brazilian men with fibromyalgia syndrome with male patients with depression.

Authors:  Gilberto Toshimitsu Yoshikawa; Roberto Ezequiel Heymann; Milton Helfenstein; Daniel Feldman Pollak
Journal:  Rheumatol Int       Date:  2009-06-27       Impact factor: 2.631

Review 2.  An insight into the gastrointestinal component of fibromyalgia: clinical manifestations and potential underlying mechanisms.

Authors:  Mahmoud Slim; Elena Pita Calandre; Fernando Rico-Villademoros
Journal:  Rheumatol Int       Date:  2014-08-14       Impact factor: 2.631

Review 3.  Societal and patient burden of fibromyalgia syndrome.

Authors:  Lieven Annemans; Katell Le Lay; Charles Taïeb
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

4.  Health-related quality of life in women with fibromyalgia: clinical and psychological factors associated.

Authors:  Ricardo Pereira Campos; Maria Isabel Vázquez Rodríguez; Maria Isabel Rodríguez Vázquez
Journal:  Clin Rheumatol       Date:  2011-10-07       Impact factor: 2.980

Review 5.  Health-related quality of life in patients with myofascial pain syndrome.

Authors:  Reyhan Celiker; Ayçe Atalay; Zeynep Guven
Journal:  Curr Pain Headache Rep       Date:  2010-10

6.  Sociodemographic characteristics, clinical signs and quality of life in patients with fibromyalgia.

Authors:  Aysegul Kucukali Turkyilmaz; Emine Eda Kurt; Murat Karkucak; Erhan Capkin
Journal:  Eurasian J Med       Date:  2012-08

7.  The impact of Fibromyalgia on health-related quality of life in patients according to age.

Authors:  Ricardo Pereira Campos; Maria Isabel Vázquez
Journal:  Rheumatol Int       Date:  2012-11-15       Impact factor: 2.631

8.  Risk factors for fibromyalgia: the role of violence against women.

Authors:  Isabel Ruiz-Pérez; Juncal Plazaola-Castaño; Rafael Cáliz-Cáliz; Isabel Rodríguez-Calvo; Antonio García-Sánchez; Miguel Angel Ferrer-González; Manuel Guzmán-Ubeda; María del Río-Lozano; Isabel López-Chicheri García
Journal:  Clin Rheumatol       Date:  2009-03-10       Impact factor: 2.980

9.  Comorbidity of fibromyalgia and cervical myofascial pain syndrome.

Authors:  Burcu Duyur Cakit; Suhan Taskin; Baris Nacir; Irem Unlu; Hakan Genc; Hatice Rana Erdem
Journal:  Clin Rheumatol       Date:  2010-04       Impact factor: 2.980

Review 10.  The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12.

Authors:  D L Hoffman; E M Dukes
Journal:  Int J Clin Pract       Date:  2007-11-24       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.